These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 18697252)
21. [Dynamics of cognitive and emotional-volitional disorders in children and adolescents with refractory epilepsy during the treatment with levetiracetam]. Popov IuV; Iakovleva IuA Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(5 Pt 2):48-52. PubMed ID: 23739514 [TBL] [Abstract][Full Text] [Related]
22. Use of donepezil in the treatment of cognitive impairments of moderate traumatic brain injury. Foster M; Spiegel DR J Neuropsychiatry Clin Neurosci; 2008; 20(1):106. PubMed ID: 18305293 [No Abstract] [Full Text] [Related]
23. [4th International Symposium. "Cerebrolysin: pharmacological effects and role in clinical practice"]. Gomazkov OA Zh Nevrol Psikhiatr Im S S Korsakova; 2002; 102(9):69-70. PubMed ID: 12378888 [No Abstract] [Full Text] [Related]
24. The nootropic and neuroprotective proline-containing dipeptide noopept restores spatial memory and increases immunoreactivity to amyloid in an Alzheimer's disease model. Ostrovskaya RU; Gruden MA; Bobkova NA; Sewell RD; Gudasheva TA; Samokhin AN; Seredinin SB; Noppe W; Sherstnev VV; Morozova-Roche LA J Psychopharmacol; 2007 Aug; 21(6):611-9. PubMed ID: 17092975 [TBL] [Abstract][Full Text] [Related]
25. [The treatment of mild cognitive disorders]. Zakharov VV Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(12):121-5. PubMed ID: 24596976 [No Abstract] [Full Text] [Related]
26. Improvement of cognitive impairment following delayed CO encephalopathy. Song IU; Cho HJ; Kim YD; Chung SW Can J Neurol Sci; 2011 Nov; 38(6):934-5. PubMed ID: 22030437 [No Abstract] [Full Text] [Related]
27. [The use of memotropil for treatment of mild cognitive impairment in out-patients with progressive chronic cerebrovascular disorders]. Batysheva TT; Bagir' LV; Kostenko EV; Artemova IIu; Bdovichenko TV; Gazhula PA; Zhuravleva EIu; Ismailov AM; Lisenker LN; Nesterova OV; Otcheskaia OV; Rotor LD; Khozova AA; Boĭko AN Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(1):40-44. PubMed ID: 18689009 [No Abstract] [Full Text] [Related]
28. [Application of nootropic agents in complex treatment of patients with concussion of the brain]. Tkachev AV Lik Sprava; 2007; (5-6):82-5. PubMed ID: 18418926 [TBL] [Abstract][Full Text] [Related]
29. [Vinpotropile in the treatment of cerebral vascular diseases]. Filimonov VA; Kliueva VN; Kondrasheva IN Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(2):58-60. PubMed ID: 18689000 [No Abstract] [Full Text] [Related]
30. [Efficacy of acatinol memantine in mild cognitive disorder]. Levin OS; Iunishchenko NA; Dudarova MA Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(7):36-42. PubMed ID: 19672236 [TBL] [Abstract][Full Text] [Related]
31. Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT). Zafonte RD; Bagiella E; Ansel BM; Novack TA; Friedewald WT; Hesdorffer DC; Timmons SD; Jallo J; Eisenberg H; Hart T; Ricker JH; Diaz-Arrastia R; Merchant RE; Temkin NR; Melton S; Dikmen SS JAMA; 2012 Nov; 308(19):1993-2000. PubMed ID: 23168823 [TBL] [Abstract][Full Text] [Related]
33. Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders. Malykh AG; Sadaie MR Drugs; 2010 Feb; 70(3):287-312. PubMed ID: 20166767 [TBL] [Abstract][Full Text] [Related]
34. [Piracetam as a corrector of long-term learning disorders caused by prenatal alcohol exposure: the significance of the length of therapy]. Trofimov SS; Ostrovskaia RU; Smol'nikova NM; Kravchenko EV; Nemova EP; Voronina TA Biull Eksp Biol Med; 1996 Apr; 121(4):435-7. PubMed ID: 8829460 [No Abstract] [Full Text] [Related]
35. [Efficacy of noopept in discirculatory encephalopathy]. Barantsevich ER; Posokhina OV; Sturova IuV Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(5):62-4. PubMed ID: 19938275 [No Abstract] [Full Text] [Related]
36. [Electrophysiological correlates of efficacy of nootropic drugs in the treatment of consequences of traumatic brain injury in adolescents]. Iznak EV; Iznak AF; Pankratova EA; Zavadenko NN; Guzilova LS; Guzilova IuI Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(5 Pt 1):27-32. PubMed ID: 21322822 [TBL] [Abstract][Full Text] [Related]
37. Piracetam prevents cognitive decline in coronary artery bypass: a randomized trial versus placebo. Szalma I; Kiss A; Kardos L; Horváth G; Nyitrai E; Tordai Z; Csiba L Ann Thorac Surg; 2006 Oct; 82(4):1430-5. PubMed ID: 16996947 [TBL] [Abstract][Full Text] [Related]
38. [State of the hemostasis system and pathogenetic therapy of circulatory encephalopathy]. Bekuzarova MR; Burd GS; Kolesnikova TI; Iasamanova AN; Kabanov AA Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(6):35-8. PubMed ID: 11517473 [No Abstract] [Full Text] [Related]